![](/img/cover-not-exists.png)
1O Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab
Mazzaschi, G., Facchinetti, F., Madeddu, D., Buti, S., Gelsomino, F., Ardizzoni, A., Aversa, F., Missale, G., Quaini, F., Tiseo, M.Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/S1556-0864(18)30281-8
Date:
April, 2018
File:
PDF, 139 KB
english, 2018